• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    HC Wainwright & Co. reiterated coverage on TherapeuticsMD with a new price target

    11/12/21 6:03:07 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $TXMD alert in real time by email
    HC Wainwright & Co. reiterated coverage of TherapeuticsMD with a rating of Buy and set a new price target of $3.00 from $4.00 previously
    Get the next $TXMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TXMD

    DatePrice TargetRatingAnalyst
    3/11/2022$3.00 → $2.50Buy
    HC Wainwright & Co.
    11/12/2021$4.00 → $3.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $TXMD
    SEC Filings

    See more
    • SEC Form 10-Q filed by TherapeuticsMD Inc.

      10-Q - TherapeuticsMD, Inc. (0000025743) (Filer)

      5/13/25 4:37:27 PM ET
      $TXMD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - TherapeuticsMD, Inc. (0000025743) (Filer)

      5/13/25 4:15:21 PM ET
      $TXMD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form 10-K/A filed by TherapeuticsMD Inc.

      10-K/A - TherapeuticsMD, Inc. (0000025743) (Filer)

      4/30/25 5:00:11 PM ET
      $TXMD
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $TXMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on TherapeuticsMD with a new price target

      HC Wainwright & Co. reiterated coverage of TherapeuticsMD with a rating of Buy and set a new price target of $2.50 from $3.00 previously

      3/11/22 6:31:06 AM ET
      $TXMD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. reiterated coverage on TherapeuticsMD with a new price target

      HC Wainwright & Co. reiterated coverage of TherapeuticsMD with a rating of Buy and set a new price target of $3.00 from $4.00 previously

      11/12/21 6:03:07 AM ET
      $TXMD
      Biotechnology: Pharmaceutical Preparations
      Health Care